COVID vaccines
Japan approves Novavax COVID vaccine, adding fourth option
Jab, different from Pfizer and Moderna's mRNA vaccines, provides 'diversity'
Health Care
Health Care
South Korea senior care industry gets smart boost
Aging population sparks need for services but cost pressures limit profitability
Pharmaceuticals
Eisai reboots search for blockbuster Alzheimer's drug
Failure to strike gold with Aduhelm prompts renewed focus on successor
Coronavirus
New COVID-19 'deltacron' variant confirmed in Brazil
Mixed variant has traits of delta and omicron, but details still scarce
Companies
Top Glove sees little impact from Ukraine war, monitors payments
2Q profit plunges 97% as selling prices decline for medical-grade products
Health Care
'Walking' wheelchair takes step toward 2023 launch in Japan
Mobility startup LifeHub raises more than $800,000 in seed funding
Pharmaceuticals
Kirin leans into health products and drugs, pouring in $900m
Majority of growth investment set aside for these segments for 1st time
The Big Story
Asia's femtech revolution: the quest for better women's health
Underserved by mainstream health care, women from India to Japan turn to technology
Health Care
Japan COVID crisis shows flaws in medical system: Nikkei and JCER
Research group urges tighter rein on hospitals and speedier drug authorization
Coronavirus
Chinese healthcare companies hit COVID jackpot with home-test kits
Overseas sales boom as omicron rages, but pandemic's end will clip windfall
Coronavirus
Xi raises pressure on Lam over Hong Kong COVID surge
Chinese leader calls for 'all necessary measures' to stop city's worst outbreak
Coronavirus
Pfizer COVID pill approved in Japan, following Merck treatment
Concerns over supply emerge as nations race to secure drugs for their people
Beijing Winter Olympics
Beijing district orders 2m people to test for virus ahead of Olympics
People in risk areas shall not leave the capital, city spokesperson says
Health Care
Southeast Asian hospitals look to high-tech future in metaverse
Malaysia's IHH, Indonesia's Siloam see big opportunities in VR, other tech
Interview
Malaysia's IHH says medical tourism to grow past pre-COVID levels
Hospital chain looks to M&As as Asia's aging population fuels health care demand
Business deals
Samsung BioLogics says report on Biogen deal talks untrue
Korea Economic Daily said Alzheimer's drug creator possibly worth $42bn
Market Spotlight
Asia's lesser-known tech manufacturers shine in 2021 stock market
Chinese education companies are biggest losers; Alibaba and Tencent tumble
Interview
International travel bans don't work for COVID, ex-CDC chief says
Regular and repeated testing crucial, but not blanket shutdowns, Robert Redfield argues
COVID vaccines
Turkey begins production of own 'better than Sinovac' vaccine
Government promises to share Turkovac, but some question hurried approval process
Pharmaceuticals
Japan says Eisai-Biogen's Alzheimer drug hard to assess
Ministry needs more data after inconsistent findings, despite U.S. approval
